HUMAW
Financials
- Market Capitalization 150.973 M
- Employee 184
- Founded 2004
- CEO Laura Niklason
- Website www.humacyte.com
- Headquarter Delaware, United States
- FIGI BBG00XPPT7S7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 7181 |  SRZNW Surrozen, Inc. - Warrant | 0.0066 USD | -48.44% | -31.25% | -34.65% | -63.13% | 253.80 M USD | ||
| 7270 |  YDESW YD Bio Limited - Warrants | 0.2601 USD | +0.04% | +18.01% | +3.96% | -52.71% | 160.69 M USD | ||
| 7285 |  FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 18.81 USD | +0.32% | -0.95% | -7.11% | +149.14% | 135.59 M USD | ||
| 7288 |  ENGNW enGene Therapeutics Inc. - Warrants | 0.3079 USD | 0.00% | -3.78% | +20.27% | -64.61% | 126.61 M USD |
Frequently asked questions about Humacyte, Inc. - Warrant
What is the Humacyte, Inc. - Warrant stock price today?
The current price of Humacyte, Inc. - Warrant (HUMAW) is 0.0091. Over the past 24 hours, the stock has changed by +19.74%. Follow the HUMAW chart for real-time price dynamics.
What is the stock ticker of Humacyte, Inc. - Warrant?
Humacyte, Inc. - Warrant trades under the ticker HUMAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Humacyte, Inc. - Warrant stock going up?
HUMAW has changed by -9.00% over the last week, -54.50% over the last month, and -98.18% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Humacyte, Inc. - Warrant net income for the last quarter?
Humacyte, Inc. - Warrant reported net income of -17.62 M for the last quarter. The previous quarter showed -24.8 M, which means net income changed by +28.97%.
How many employees does Humacyte, Inc. - Warrant have?
As of the latest available data, Humacyte, Inc. - Warrant has 184 employees. Workforce size can provide additional context about the company's scale and operations.
What is Humacyte, Inc. - Warrant EBITDA?
Humacyte, Inc. - Warrant EBITDA is -26.86 M, and its EBITDA margin is -5 426.87%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Humacyte, Inc. - Warrant stock?
You can buy Humacyte, Inc. - Warrant (HUMAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Humacyte, Inc. - Warrant stock?
Investing in Humacyte, Inc. - Warrant requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HUMAW chart and related analysis on metatrader.com as part of your research.